
Kent Iverson |
Over the past five
years, manufacturing has emerged as key area of risk and opportunity
in the development of biopharmaceutical products.
As the focus of the biopharmaceutical
industry has shifted from discovery towards development, the ability
to reliably and economically supply biopharmaceutical products has
become a major determinant of success. At the same time the growth
of the biopharmaceutical industry has stretched the collective human
resources to the point where many biopharmaceutical companies do not
have the experience and skills necessary to address the needs and
challenges in front of them. Recognizing this dynamic within the industry,
Kent Iverson established a consulting practice in October 2001 to
leverage his skills and experience in the areas of biopharmaceutical
manufacturing and development. Kent has helped numerous companies
in the US and Europe achieve their biopharmaceutical manufacturing
and development objectives. |
|